Latest Hodgkin's lymphoma Stories
WHITE PLAINS, N.Y., June 27, 2012 /PRNewswire/ -- Tap your inner superhero and grab your shield: the inaugural Herothon Half Marathon Series Powered by The Leukemia & Lymphoma Society takes flight this winter! The Leukemia & Lymphoma Society (LLS), which has operated the world's biggest and most successful endurance sports training program, Team In Training (TNT), for the past 24 years, is now spreading its wings with this new endurance series of its own. The Herothon...
Trial led by St. Jude Children's Research Hospital investigators succeeds in keeping cure rates high for young patients with favorable-risk Hodgkin lymphoma while reducing their chances of serious treatment side effects MEMPHIS, Tenn., June 26, 2012 /PRNewswire-USNewswire/ -- A multicenter trial showed that nearly half of young patients with early-stage Hodgkin lymphoma can be cured without undergoing either irradiation or intensive chemotherapy that would leave them at risk for...
The same growth factor was previously shown to reverse memory decline in Alzheimer’s mice Growth factors shown to cure Alzheimer’s disease in a mouse model and administered to cancer patients as part of their treatment regimen were linked to significant improvements in the patients’ cognitive function following stem cell transplantation, a preliminary clinical study reports. The findings by researchers at the USF Health Byrd Alzheimer’s Institute and Moffitt Cancer Center are...
SEATTLE, June 20, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC), a company focused on translating science into novel cancer therapies, today announced that it is re-aligning its resources and re-prioritizing its product development pipeline to focus on the launch of Pixuvri in the EU and accelerate the advancement of pacritinib, CTI's recently-acquired, highly-selective JAK 2 inhibitor, into phase III clinical trials. As a result, CTI's operating...
Spirited 10-week fundraising competition introduced powerful new techniques to raise money for vital blood cancer research and patient services. SAN FRANCISCO, June 18, 2012 /PRNewswire-USNewswire/ -- The Greater San Francisco Bay Area Chapter of The Leukemia & Lymphoma Society (LLS) announced the results of its 22nd annual "Man & Woman of the Year" campaign - in which candidates introduced innovative fundraising techniques that garnered headlines around the world - at the...
The San Francisco Bay Area chapter of The Leukemia & Lymphoma Society’s (LLS) Team In Training (TNT) was represented once again during the Olympic Torch Relay. San Francisco, CA (PRWEB) June 16, 2012 The London 2012 Olympic Games begin on July 22 and the Olympic Torch Relay is currently underway. Earlier this month, San Francisco Bay Area endurance sports training and charity program, The Leukemia & Lymphoma Society’s (LLS) Team In Training (TNT), was represented once again...
AMSTERDAM, June 15, 2012 /PRNewswire/ -- "Hodgkin lymphoma has become one of the most curable malignancies in adults," was stated by Dr Andreas Engert, Professor of Hematology at the University Hospital of Cologne in Germany. Results of the German Hodgkin Study Group (GHSG) HD 15 trial are presented at the 17th Congress of the European Hematology Association in Amsterdam. Using the multi-agent chemotherapy regimen BEACOPP the GHSG demonstrated significantly better tumor...
BERLIN and BRUSSELS, June 6, 2012 /PRNewswire/ -- Results from the RAPID(TM)-PsA study presented this week at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology in Germany showed that certolizumab pegol compared to placebo improved the signs and symptoms of arthritis in adult patients with active psoriatic arthritis (PsA). "Certolizumab pegol has been shown to be clinically effective in moderate to severe rheumatoid arthritis. The RAPID(TM)-PsA...
Survivors of childhood cancers are at an increased risk of another battle with cancer later in life, according to new research published online June 4 by the Annals of Internal Medicine. In the largest study to date of risk for gastrointestinal (GI) cancers among people first diagnosed with cancer before the age of 21, researchers found that childhood cancer survivors develop these malignancies at a rate nearly five times that of the general population. While there was some preliminary...
Connie K. Ho for redOrbit.com Chemotherapy, radiation therapy and surgery are just a few of the treatments cancer patients undergo. These treatments may be risky, especially for those who are diagnosed with cancer at a young age. A new study led by Dr. Chaya Moskowitz included data that showed women who were treated with radiation to the chest for childhood cancer had a greater chance of developing breast cancer that was similar to women who had BRCA1/2 mutations. The study was revealed...
